New Alcohol-related Condition Diagnoses Are Associated With Opioid Tapers Among Patients Receiving Long-term Opioid Therapy

  • 0From the Division of General Internal Medicine, University of Colorado School of Medicine, Aurora, CO (JDP, IAB); Department of Medicine, Denver Health Hospital Authority, Denver, CO (JDP); Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO (JDP, KJN, APN, JMG, IAB); Department of Epidemiology, Colorado School of Public Health, Aurora, CO (JMG); Chemical Dependency Treatment Services, Colorado Permanente Medical Group, Denver, CO (IAB); and Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA (IAB).

|

|

Summary

This summary is machine-generated.

Patients on decreasing long-term opioid therapy (LTOT) doses face a higher risk of developing new alcohol-related conditions (ARCs). Routine screening for alcohol use during LTOT tapers can aid early detection and intervention.

Area Of Science

  • Pain Management
  • Addiction Medicine
  • Public Health

Background

  • Chronic pain patients often receive long-term opioid therapy (LTOT).
  • Alcohol-related conditions (ARCs) are a concern in this population.
  • Understanding the interplay between LTOT dose changes and ARCs is crucial.

Purpose Of The Study

  • To examine the association between ARCs and LTOT dose trajectories.
  • To investigate if ARCs moderate the link between LTOT tapers and mortality.

Main Methods

  • Retrospective cohort study of 3912 patients on LTOT.
  • Multinomial regression for ARC association with LTOT dose.
  • Competing risks regression for LTOT trajectories and new ARCs.
  • Cox-proportional hazards models for mortality moderation.

Main Results

  • 6.2% of patients had pre-existing ARCs; no association with LTOT trajectory.
  • Patients on decreasing LTOT doses were twice as likely to develop new ARCs (aHR 2.23).
  • ARCs did not significantly moderate the LTOT trajectory-mortality relationship.

Conclusions

  • Decreasing LTOT dose trajectories increase the risk of new ARCs.
  • Routine alcohol use screening is recommended for patients tapering LTOT.
  • Interventions to reduce alcohol use may mitigate LTOT taper-related harms.

Related Concept Videos

CNS Depressants: Alcohol and Nicotine 01:27

174

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...

Opioid Analgesics: Synthetic and Semisynthetic Opioids 01:15

225

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...

Opioid Analgesics: Morphine and Other Natural Cogeners 01:20

183

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...

Substance Use Disorders Affecting Sleep 01:24

160

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...

Analgesia and Pain Management 01:25

513

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...

Drug Abuse and Addiction: Pharmacological Phenomena 01:15

444

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...